$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 2,500 | 15,150 | 365,358 | 362.9 K to 365.4 K (+0.69 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 10,481 | 0 | 195,831 | 185.4 K to 195.8 K (+5.65 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 4,803 | 0 | 195,225 | 190.4 K to 195.2 K (+2.52 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 11,354 | 0 | 522,253 | 510.9 K to 522.3 K (+2.22 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 40,615 | 0 | 949,696 | 909.1 K to 949.7 K (+4.47 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.08 | 9,755 | 88,608 | 909,081 | 918.8 K to 909.1 K (-1.06 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 7,500 | 45,450 | 52,500 | |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 14,847 | 0 | 362,858 | 348 K to 362.9 K (+4.27 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.09 | 15,003 | 136,310 | 348,011 | 363 K to 348 K (-4.13 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 7,500 | 45,450 | 363,014 | 355.5 K to 363 K (+2.11 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 10,481 | 0 | 166,954 | 156.5 K to 167 K (+6.70 %) |
| Mar 30 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 9.44 | 422 | 3,984 | 20,067 | 20.5 K to 20.1 K (-2.06 %) |
| Mar 24 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 162,485 | |
| Mar 24 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.00 | 20,000 | 180,000 | 918,836 | 938.8 K to 918.8 K (-2.13 %) |
| Mar 24 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 938,836 | 918.8 K to 938.8 K (+2.18 %) |
| Mar 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 0 | |
| Mar 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 355,514 | 358 K to 355.5 K (-0.70 %) |
| Mar 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 358,014 | 355.5 K to 358 K (+0.70 %) |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.10 | 9,755 | 88,745 | 918,836 | 928.6 K to 918.8 K (-1.05 %) |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 2,500 | |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.09 | 15,003 | 136,445 | 355,514 | 370.5 K to 355.5 K (-4.05 %) |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 370,517 | 363 K to 370.5 K (+2.07 %) |
| Feb 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 182,485 | |
| Feb 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.83 | 20,000 | 216,676 | 928,591 | 948.6 K to 928.6 K (-2.11 %) |
| Feb 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 948,591 | 928.6 K to 948.6 K (+2.15 %) |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 5.13 | 17,652 | 90,555 | 19,133 | |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 6.10 | 29,148 | 177,803 | 6,270 | |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 8.61 | 6,300 | 54,243 | 43,700 | |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 11.01 | 63,356 | 697,340 | 510,899 | 574.3 K to 510.9 K (-11.03 %) |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 5.13 | 17,652 | 90,555 | 574,255 | 556.6 K to 574.3 K (+3.17 %) |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 6.10 | 29,148 | 177,803 | 556,603 | 527.5 K to 556.6 K (+5.53 %) |
| Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 8.61 | 6,300 | 54,243 | 527,455 | 521.2 K to 527.5 K (+1.21 %) |
| Feb 07 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 10,000 | |
| Feb 07 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 363,017 | 365.5 K to 363 K (-0.68 %) |
| Feb 07 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 365,517 | 363 K to 365.5 K (+0.69 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 12,500 | |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 8.91 | 15,003 | 133,626 | 363,017 | 378 K to 363 K (-3.97 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 378,020 | 370.5 K to 378 K (+2.02 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 8.91 | 9,754 | 86,882 | 928,591 | 938.3 K to 928.6 K (-1.04 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 8.84 | 19,994 | 176,747 | 938,345 | 958.3 K to 938.3 K (-2.09 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Sell | S | 10.35 | 22,100 | 228,642 | 185,350 | 207.5 K to 185.4 K (-10.65 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 10.35 | 20,720 | 214,359 | 156,473 | 177.2 K to 156.5 K (-11.69 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.35 | 5,064 | 52,388 | 370,520 | 375.6 K to 370.5 K (-1.35 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 202,485 | |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.35 | 100,000 | 1,034,790 | 958,339 | 1.1 M to 958.3 K (-9.45 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 1,058,339 | 1 M to 1.1 M (+1.93 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.46 | 18,728 | 177,167 | 207,450 | 226.2 K to 207.5 K (-8.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 40,828 | 0 | 226,178 | 185.4 K to 226.2 K (+22.03 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.46 | 18,728 | 177,167 | 207,450 | 226.2 K to 207.5 K (-8.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.46 | 12,065 | 114,135 | 190,422 | 202.5 K to 190.4 K (-5.96 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 40,828 | 0 | 226,178 | 185.4 K to 226.2 K (+22.03 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 24,496 | 0 | 202,487 | 178 K to 202.5 K (+13.76 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.46 | 12,065 | 114,135 | 190,422 | 202.5 K to 190.4 K (-5.96 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 24,496 | 0 | 202,487 | 178 K to 202.5 K (+13.76 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.46 | 18,904 | 178,832 | 521,155 | 540.1 K to 521.2 K (-3.50 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 40,828 | 0 | 540,059 | 499.2 K to 540.1 K (+8.18 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.46 | 18,904 | 178,832 | 521,155 | 540.1 K to 521.2 K (-3.50 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.46 | 64,264 | 607,937 | 1,038,339 | 1.1 M to 1 M (-5.83 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 40,828 | 0 | 540,059 | 499.2 K to 540.1 K (+8.18 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 163,313 | 0 | 1,102,603 | 939.3 K to 1.1 M (+17.39 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.46 | 64,264 | 607,937 | 1,038,339 | 1.1 M to 1 M (-5.83 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.46 | 29,492 | 278,994 | 375,584 | 405.1 K to 375.6 K (-7.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 163,313 | 0 | 1,102,603 | 939.3 K to 1.1 M (+17.39 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 59,881 | 0 | 405,076 | 345.2 K to 405.1 K (+17.35 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.46 | 29,492 | 278,994 | 375,584 | 405.1 K to 375.6 K (-7.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 59,881 | 0 | 405,076 | 345.2 K to 405.1 K (+17.35 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.46 | 20,108 | 190,222 | 177,193 | 197.3 K to 177.2 K (-10.19 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 40,828 | 0 | 197,301 | 156.5 K to 197.3 K (+26.09 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.46 | 20,108 | 190,222 | 177,193 | 197.3 K to 177.2 K (-10.19 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 40,828 | 0 | 197,301 | 156.5 K to 197.3 K (+26.09 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 20,000 | 66,400 | 0 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.00 | 20,000 | 200,000 | 22,064 | 42.1 K to 22.1 K (-47.55 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 20,000 | 66,400 | 42,064 | 22.1 K to 42.1 K (+90.65 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 20,000 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 345,195 | 347.7 K to 345.2 K (-0.72 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 347,695 | 345.2 K to 347.7 K (+0.72 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 4.38 | 1,200 | 5,256 | 7,550 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.52 | 9,822 | 24,751 | 0 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 4.38 | 1,200 | 5,256 | 177,991 | 176.8 K to 178 K (+0.68 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.52 | 9,822 | 24,751 | 176,791 | 167 K to 176.8 K (+5.88 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 9.93 | 15,000 | 148,952 | 166,969 | 182 K to 167 K (-8.24 %) |
| Jan 08 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 9.36 | 9,938 | 92,980 | 156,473 | 166.4 K to 156.5 K (-5.97 %) |
| Jan 08 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 9.28 | 6,836 | 63,415 | 166,411 | 173.2 K to 166.4 K (-3.95 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.18 | 19,994 | 183,545 | 939,290 | 959.3 K to 939.3 K (-2.08 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.18 | 13,973 | 128,272 | 345,195 | 359.2 K to 345.2 K (-3.89 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.55 | 12,161 | 116,138 | 359,168 | 371.3 K to 359.2 K (-3.27 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Option Exercise | A | 9.55 | 91,439 | 873,242 | 91,439 | |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Payment of Exercise | F | 9.55 | 5,612 | 53,595 | 153,728 | 159.3 K to 153.7 K (-3.52 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 58,179 | 0 | 159,340 | 101.2 K to 159.3 K (+57.51 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | A | 9.55 | 15,127 | 144,463 | 15,127 | |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 9.55 | 553 | 5,281 | 20,489 | 21 K to 20.5 K (-2.63 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 9,625 | 0 | 21,042 | 11.4 K to 21 K (+84.30 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.18 | 5,305 | 48,700 | 181,969 | 187.3 K to 182 K (-2.83 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.55 | 7,113 | 67,929 | 187,274 | 194.4 K to 187.3 K (-3.66 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.18 | 8,980 | 82,436 | 185,350 | 194.3 K to 185.4 K (-4.62 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 9.55 | 7,002 | 66,869 | 194,330 | 201.3 K to 194.3 K (-3.48 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.18 | 9,330 | 85,649 | 499,231 | 508.6 K to 499.2 K (-1.83 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.55 | 7,067 | 67,490 | 508,561 | 515.6 K to 508.6 K (-1.37 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.18 | 9,642 | 88,514 | 173,247 | 182.9 K to 173.2 K (-5.27 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.55 | 6,633 | 63,345 | 182,889 | 189.5 K to 182.9 K (-3.50 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 9.55 | 96,818 | 924,612 | 96,818 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 9.55 | 9,753 | 93,173 | 189,522 | 199.3 K to 189.5 K (-4.89 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 61,601 | 0 | 199,275 | 137.7 K to 199.3 K (+44.74 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 9.74 | 10,826 | 105,445 | 137,674 | 148.5 K to 137.7 K (-7.29 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 9.55 | 107,575 | 1,027,341 | 107,575 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 68,446 | 0 | 515,628 | 447.2 K to 515.6 K (+15.31 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.74 | 10,219 | 99,533 | 447,182 | 457.4 K to 447.2 K (-2.23 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 9.55 | 112,954 | 1,078,711 | 112,954 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 71,868 | 0 | 194,387 | 122.5 K to 194.4 K (+58.66 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.74 | 6,735 | 65,599 | 122,519 | 129.3 K to 122.5 K (-5.21 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 22,500 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 9.55 | 188,257 | 1,797,854 | 188,257 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.61 | 7,500 | 72,039 | 359,140 | 366.6 K to 359.1 K (-2.05 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 366,640 | 359.1 K to 366.6 K (+2.09 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.56 | 14,627 | 139,850 | 359,140 | 373.8 K to 359.1 K (-3.91 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 119,780 | 0 | 373,767 | 254 K to 373.8 K (+47.16 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.74 | 15,556 | 151,515 | 253,987 | 269.5 K to 254 K (-5.77 %) |
| Dec 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 222,485 | |
| Dec 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.55 | 20,000 | 191,014 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Dec 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Dec 04 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 31,439 | |
| Dec 04 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.38 | 20,000 | 207,618 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Dec 04 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Nov 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 40,000 | 152,800 | 51,439 | |
| Nov 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.01 | 40,000 | 400,204 | 735,694 | 775.7 K to 735.7 K (-5.16 %) |
| Nov 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 40,000 | 152,800 | 775,694 | 735.7 K to 775.7 K (+5.44 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 242,485 | |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.52 | 20,000 | 190,390 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 242,485 | |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.52 | 20,000 | 190,390 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Nov 12 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 262,485 | |
| Nov 12 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.02 | 20,000 | 180,414 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Nov 12 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Oct 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 8.01 | 14,500 | 116,073 | 735,694 | 750.2 K to 735.7 K (-1.93 %) |
| Oct 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Payment of Exercise | F | 7.48 | 6,896 | 51,582 | 101,161 | 108.1 K to 101.2 K (-6.38 %) |
| Sep 13 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 91,439 | |
| Sep 13 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.05 | 20,000 | 201,030 | 750,194 | 770.2 K to 750.2 K (-2.60 %) |
| Sep 13 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,194 | 750.2 K to 770.2 K (+2.67 %) |
| Aug 27 2019 | FOLD | AMICUS THERAPEUTIC ... | WHITMAN BURKE W | Director | Buy | P | 10.07 | 4,945 | 49,796 | 21,612 | 16.7 K to 21.6 K (+29.67 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 111,439 | |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 111,439 | |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.54 | 20,000 | 250,736 | 750,194 | 770.2 K to 750.2 K (-2.60 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.54 | 20,000 | 250,736 | 750,194 | 770.2 K to 750.2 K (-2.60 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,194 | 750.2 K to 770.2 K (+2.67 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,194 | 750.2 K to 770.2 K (+2.67 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | Bleil Lynn Dorsey | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | Bleil Lynn Dorsey | Director | Grant | A | 0.00 | 6,250 | 0 | 15,850 | 9.6 K to 15.9 K (+65.10 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | WHITMAN BURKE W | Director | Option Exercise | A | 12.00 | 25,964 | 311,568 | 25,964 |